A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult

INTRODUCTION: This study aims to assess the economic impact of introducing the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) to Thai older adult aged ≥ 65  years who are healthy or with chronic health conditions and immunocompromised cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngamprasertchai, Thundon, Kositamongkol, Chayanis, Lawpoolsri, Saranath, Rattanaumpawan, Pinyo, Luvira, Viravarn, Chongtrakool, Piriyaporn, Kaewkungwal, Jaranit, Chokephaibulkit, Kulkanya, Phisalprapa, Pochamana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339832/
https://www.ncbi.nlm.nih.gov/pubmed/37457251
http://dx.doi.org/10.3389/fpubh.2023.1071117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339832/
https://www.ncbi.nlm.nih.gov/pubmed/37457251
http://dx.doi.org/10.3389/fpubh.2023.1071117

Ejemplares similares